PJ

Pareshkumar Jaysukhlal Shah

Active Director Director DIN 05236420
DIN 05236420 First appointment Mar 2012 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Mar 2012
Shareholding value •••• Premium profile

About Pareshkumar Jaysukhlal Shah

Data last updated:

Pareshkumar Jaysukhlal Shah is a Director at Athasis Lifecare Private Limited (since 2020), Director at Makshil Remedies Private Limited (since 2020) and Director at Flourish Pharma Limited (since 2025), and holds 2 more current directorships. The companies operate in Chemicals and Materials, Real Estate and Construction and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹10.21 Cr; the largest is Athasis Lifecare Private Limited at ₹8.97 Cr (FY 2024). Earlier, Pareshkumar Jaysukhlal Shah was a Director at Twilight Reality & Developers Private Limited (2012–2014).

DIN 05236420
Primary Designation Director
Industry Chemicals and Materials
First Appointment 10 Mar 2012
Oldest Company Age 11 yrs
Largest company Athasis Lifecare Private Limited · ₹8.97 Cr (FY 2024)
Combined revenue ₹10.21 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Athasis Lifecare Private Limited U51909GJ2020PTC118783
Director10 Dec 20202020₹8.97 Cr (FY 2024)Active
Makshil Remedies Private Limited U24230GJ2020PTC117127
Director08 Oct 20202020₹1.24 Cr (FY 2024)Active
Flourish Pharma Limited U46692DD2025PLC010084
Director01 Aug 20252025Active
Designated Partner01 Jul 20192019Active
Partner31 Mar 20152015Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Mar 20122008Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mas Infra Project Llp
Makshil Remedies Private Limited
Athasis Lifecare Private Limited
Twilight Reality & Developers Llp
Premium access

Shareholding and investment profile for Pareshkumar Jaysukhlal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pareshkumar Jaysukhlal Shah

Pareshkumar Jaysukhlal Shah currently holds 5 directorships: Athasis Lifecare Private Limited (Director, since 10 Dec 2020, revenue ₹8.97 Cr (FY 2024)); Makshil Remedies Private Limited (Director, since 08 Oct 2020, revenue ₹1.24 Cr (FY 2024)); Flourish Pharma Limited (Director, since 01 Aug 2025); Mas Infra Project Llp (Designated Partner, since 01 Jul 2019); Twilight Reality & Developers Llp (Partner, since 31 Mar 2015).

Pareshkumar Jaysukhlal Shah was first appointed on 10 Mar 2012 as Director at Twilight Reality & Developers Private Limited. The most recent appointment on record is 01 Aug 2025 at Flourish Pharma Limited.

The 2 current companies of Pareshkumar Jaysukhlal Shah that report revenue have a combined latest revenue of ₹10.21 Cr: Athasis Lifecare Private Limited ₹8.97 Cr (FY 2024); Makshil Remedies Private Limited ₹1.24 Cr (FY 2024).

Pareshkumar Jaysukhlal Shah held 1 earlier board appointment: Twilight Reality & Developers Private Limited (Director, 10 Mar 2012 to 02 Aug 2014).

The current boards of Pareshkumar Jaysukhlal Shah's companies include Pankilkumar Jaysukhlal Shah (Athasis Lifecare Private Limited), Tejashkumar Jaysukhlal Shah (Athasis Lifecare Private Limited), Rajeev Amritlal Mundra (Mas Infra Project Llp), Akshita Pankilkumar Shah (Twilight Reality & Developers Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available